Lmcg Investments LLC Sells 40,479 Shares of Cognex Corporation $CGNX

Key Points

• Lmcg Investments LLC has significantly reduced its holdings in Cognex Corporation by 79.3%, selling 40,479 shares, which leaves them with approximately 10,576 shares valued at $335,000.
• Cognex Corporation recently reported $0.25 earnings per share for the last quarter, surpassing analysts' expectations of $0.23, and experienced a 4.2% year-over-year revenue growth.
• The company declared a quarterly dividend of $0.08 per share, reflecting a 0.8% yield and a payout ratio of 45.07%.

Lmcg Investments LLC reduced its position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 79.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,576 shares of the scientific and technical instruments company's stock after selling 40,479 shares during the period. Lmcg Investments LLC's holdings in Cognex were worth $335,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CGNX. Geneos Wealth Management Inc. boosted its holdings in Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after purchasing an additional 736 shares during the period. Farther Finance Advisors LLC boosted its holdings in Cognex by 439.4% in the 1st quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company's stock valued at $29,000 after purchasing an additional 791 shares during the period. GAMMA Investing LLC boosted its holdings in Cognex by 155.3% in the 1st quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock valued at $32,000 after purchasing an additional 646 shares during the period. MassMutual Private Wealth & Trust FSB boosted its holdings in Cognex by 231.9% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company's stock valued at $34,000 after purchasing an additional 756 shares during the period. Finally, UMB Bank n.a. boosted its holdings in Cognex by 105.5% in the 1st quarter. UMB Bank n.a. now owns 1,280 shares of the scientific and technical instruments company's stock valued at $38,000 after purchasing an additional 657 shares during the period. 88.12% of the stock is owned by institutional investors.

Cognex Stock Performance

Shares of CGNX stock opened at $40.78 on Friday. Cognex Corporation has a 52-week low of $22.67 and a 52-week high of $47.52. The stock has a market cap of $6.85 billion, a price-to-earnings ratio of 57.44 and a beta of 1.50. The firm has a fifty day moving average of $44.20 and a 200-day moving average of $34.93.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The firm had revenue of $249.09 million during the quarter, compared to the consensus estimate of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The firm's quarterly revenue was up 4.2% on a year-over-year basis. During the same period last year, the firm posted $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, sell-side analysts predict that Cognex Corporation will post 0.61 earnings per share for the current year.

Cognex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were given a dividend of $0.08 per share. The ex-dividend date was Thursday, August 14th. This represents a $0.32 dividend on an annualized basis and a yield of 0.8%. Cognex's dividend payout ratio is 45.07%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CGNX shares. Weiss Ratings reissued a "hold (c)" rating on shares of Cognex in a report on Wednesday. Melius raised shares of Cognex from a "hold" rating to a "buy" rating and set a $60.00 price target for the company in a report on Thursday, July 10th. UBS Group increased their price target on shares of Cognex from $53.00 to $58.00 and gave the company a "buy" rating in a report on Friday, August 1st. Needham & Company LLC increased their price objective on shares of Cognex from $36.00 to $45.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Finally, Truist Financial set a $45.00 price objective on shares of Cognex and gave the company a "hold" rating in a research note on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $44.93.

Insiders Place Their Bets

In related news, EVP Sheila Marie Dipalma sold 2,000 shares of the firm's stock in a transaction on Monday, September 8th. The stock was sold at an average price of $45.03, for a total transaction of $90,060.00. Following the completion of the sale, the executive vice president directly owned 6,582 shares of the company's stock, valued at $296,387.46. This trade represents a 23.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.60% of the stock is owned by corporate insiders.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.